Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8952824 | Journal of Vascular and Interventional Radiology | 2018 | 10 Pages |
Abstract
These preliminary data suggest that genomic profiling may predict which patients with metastatic breast cancer benefit most from radioembolization. PI3K pathway mutations are associated with improved imaging response, which is associated with longer survival.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Radiology and Imaging
Authors
Amy R. MD, PhD, Christopher C. MD, PhD, Jacqueline MD, PhD, Sarat MD, PhD, Christopher A. MD, Constantinos T. MD, PhD, Hooman MD, Lynn A. MD, F. Edward MD, PhD, Etay MD, PhD,